N582 Final Exam - Women's Health / Advanced Women's
Health Nursing | 2026/2027 Edition | 250 Verified Questions
N582 Final Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam prep document contains 250 verified questions and answers with rationales
for the N582 Final Exam in Women's Health and Advanced Women's Health Nursing. Covering
essential topics such as reproductive health, pregnancy complications, gynecological disorders, and
advanced nursing interventions, this resource is meticulously aligned with the latest 2026/2027
academic guidelines. Each question includes a detailed rationale to reinforce understanding and clinical
reasoning. Ideal for graduate nursing students seeking to excel in their final examination.
Key Features:
Reproductive Health and Family Planning
Pregnancy and Postpartum Complications
Gynecological Disorders and Menopause Management
Advanced Assessment and Diagnostic Techniques
Pharmacological and Non-Pharmacological Interventions
Ethical and Legal Considerations in Women's Health
Updates for 2026:
- Integrated 2026 ACOG and CDC guidelines for prenatal care and STI management
- Added new questions on telehealth and remote monitoring in women's health
- Updated rationales to reflect current evidence-based practice and clinical trials
- Expanded coverage of LGBTQ+ reproductive health and fertility preservation
- Revised content on menopause hormone therapy based on 2027 position statements
Abstract:
This exam preparation document for N582 Final Exam in Women's Health and Advanced Women's Health Nursing
comprises 250 meticulously curated questions with verified answers and detailed rationales. Designed for
graduate-level nursing students, the content spans the full spectrum of women's health, including reproductive
physiology, antenatal and postnatal care, gynecological pathologies, and advanced nursing management. Each
question is crafted to test clinical reasoning and application of evidence-based guidelines, with rationales that
explain correct and incorrect options. The document is updated to reflect the latest 2026/2027 academic standards,
incorporating recent research findings and professional recommendations. Emphasis is placed on high-stakes
topics such as high-risk pregnancies, oncological screening, and ethical decision-making. This resource serves as
a definitive study tool for achieving a graded A+ performance on the final exam.
Keywords:
Women's Health Nursing, Advanced Nursing, Final Exam Prep, 250 Questions, Rationales, 2026/2027, Graduate
Nursing, Clinical Reasoning
Answer Format:
Each question is followed by the correct answer and a comprehensive rationale explaining why the answer is
correct and why the other options are incorrect. Distractors are analyzed to highlight common misconceptions and
clinical pitfalls, reinforcing key concepts and promoting deep understanding.
Compliance Checklist:
Aligned with 2026-2027 curriculum standards for N582
Verified answers by subject matter experts
Page 1
, Rationales cite current evidence-based sources
Covers all major content domains as per course syllabus
Updated to include latest clinical guidelines and research
Suitable for self-assessment and exam simulation
Content Area Overview:
Content Area Questions Key Topics Weight
Reproductive Health and Family 1-50 Contraception, fertility, preconception 20%
Planning counseling, STI management, menstrual
disorders
Pregnancy and Prenatal Care 51-100 Antenatal assessment, gestational diabetes, 20%
preeclampsia, multiple gestation, prenatal
screening
Intrapartum and Postpartum Care 101-150 Labor management, postpartum hemorrhage, 20%
breastfeeding, postpartum depression,
neonatal transition
Gynecological Disorders and 151-200 Uterine fibroids, endometriosis, PCOS, 20%
Menopause menopause management, osteoporosis,
pelvic floor disorders
Advanced Nursing Interventions 201-250 Advanced assessment, pharmacotherapy, 20%
and Ethics surgical care, ethical dilemmas, legal issues,
patient education
Page 2
,Q1. A 32-year-old woman presents with pelvic pain and irregular bleeding. Transvaginal ultrasound reveals
a complex adnexal mass with solid components and papillary projections. CA-125 is elevated at 350 U/mL.
Which of the following is the most appropriate next step in management?
A. Repeat CA-125 in 3 months
B. Laparoscopic cystectomy with frozen section
C. CT scan of abdomen and pelvis
D. Start oral contraceptives
Correct Answer: C. CT scan of abdomen and pelvis
Rationale: Given the complex mass with solid components and elevated CA-125, there is high suspicion for ovarian
malignancy. A CT scan of abdomen and pelvis is essential for staging and to assess for metastatic disease before
surgical planning. Repeat CA-125 or oral contraceptives delay diagnosis. Laparoscopic cystectomy without prior
staging may be inadequate for cancer.
Why Wrong:
A - Repeat CA-125 delays definitive diagnosis; imaging is needed first.
B - Laparoscopic cystectomy without preoperative staging risks incomplete surgery if malignancy is
confirmed.
D - Oral contraceptives are not indicated for suspected malignancy.
Reference: National Comprehensive Cancer Network (NCCN) Guidelines: Ovarian Cancer, 2024.
Q2. A 28-year-old primigravida at 20 weeks gestation presents with a blood pressure of 155/100 mmHg and
2+ proteinuria on dipstick. She has no prior history of hypertension. Which of the following laboratory
findings is most consistent with preeclampsia with severe features?
A. Platelet count 150,000/L
B. Serum creatinine 1.2 mg/dL
C. AST 45 U/L
D. LDH 800 U/L
Correct Answer: D. LDH 800 U/L
Rationale: Preeclampsia with severe features is diagnosed with severe hypertension and evidence of end-organ
damage. LDH > 600 U/L indicates microangiopathic hemolysis, a feature of HELLP syndrome, which is a severe
variant. Platelet count < 100,000, creatinine > 1.1 mg/dL, and AST > 70 U/L are other criteria, but LDH elevation
is the most consistent with severe disease here.
Why Wrong:
A - Platelet count 150,000 is within normal range; severe preeclampsia requires < 100,000.
B - Creatinine 1.2 mg/dL is elevated slightly but not diagnostic alone; LDH is more specific for hemolysis.
C - AST 45 U/L is mildly elevated but not meeting severe criteria (>70).
Reference: ACOG Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia, 2020.
Page 3
, Q3. A 45-year-old woman with a history of stage I estrogen receptor-positive breast cancer treated with
tamoxifen presents with new-onset vaginal bleeding. Endometrial biopsy shows complex atypical hyperplasia.
Which of the following is the most likely cause?
A. Tamoxifen-induced endometrial proliferation
B. Recurrence of breast cancer
C. Endometrial polyp
D. Endometrial atrophy
Correct Answer: A. Tamoxifen-induced endometrial proliferation
Rationale: Tamoxifen, a selective estrogen receptor modulator, has partial estrogenic effects on the endometrium,
increasing the risk of endometrial hyperplasia and cancer. Complex atypical hyperplasia is a precursor to
endometrial cancer and is a known adverse effect of tamoxifen. Breast cancer recurrence in the endometrium is
rare. Polyps and atrophy are less likely given the histology.
Why Wrong:
B - Breast cancer metastasis to endometrium is uncommon and not typical with tamoxifen use.
C - Endometrial polyps are common but do not explain complex atypical hyperplasia.
D - Endometrial atrophy is associated with postmenopausal bleeding but not hyperplasia.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 53.
Q4. A 30-year-old woman with polycystic ovary syndrome (PCOS) is being evaluated for infertility. She has a
BMI of 32 kg/m² and oligomenorrhea. Her partner's semen analysis is normal. Which of the following is the
most appropriate first-line pharmacologic treatment for ovulation induction?
A. Clomiphene citrate
B. Metformin
C. Letrozole
D. Gonadotropins
Correct Answer: C. Letrozole
Rationale: Current guidelines recommend letrozole as first-line for ovulation induction in PCOS due to higher live
birth rates and lower multiple pregnancy rates compared to clomiphene. Clomiphene is second-line. Metformin is
used for metabolic issues but not primary ovulation induction. Gonadotropins are reserved for
clomiphene/letrozole failures due to cost and risk.
Why Wrong:
A - Clomiphene is less effective than letrozole in PCOS with higher multiple pregnancy risk.
B - Metformin improves ovulation rates but is not first-line for ovulation induction.
D - Gonadotropins are more expensive and carry higher risk of multiples; reserved after oral agents fail.
Reference: Practice Committee of the ASRM. (2023). Use of letrozole for ovulation induction. Fertil Steril.
Page 4
Health Nursing | 2026/2027 Edition | 250 Verified Questions
N582 Final Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam prep document contains 250 verified questions and answers with rationales
for the N582 Final Exam in Women's Health and Advanced Women's Health Nursing. Covering
essential topics such as reproductive health, pregnancy complications, gynecological disorders, and
advanced nursing interventions, this resource is meticulously aligned with the latest 2026/2027
academic guidelines. Each question includes a detailed rationale to reinforce understanding and clinical
reasoning. Ideal for graduate nursing students seeking to excel in their final examination.
Key Features:
Reproductive Health and Family Planning
Pregnancy and Postpartum Complications
Gynecological Disorders and Menopause Management
Advanced Assessment and Diagnostic Techniques
Pharmacological and Non-Pharmacological Interventions
Ethical and Legal Considerations in Women's Health
Updates for 2026:
- Integrated 2026 ACOG and CDC guidelines for prenatal care and STI management
- Added new questions on telehealth and remote monitoring in women's health
- Updated rationales to reflect current evidence-based practice and clinical trials
- Expanded coverage of LGBTQ+ reproductive health and fertility preservation
- Revised content on menopause hormone therapy based on 2027 position statements
Abstract:
This exam preparation document for N582 Final Exam in Women's Health and Advanced Women's Health Nursing
comprises 250 meticulously curated questions with verified answers and detailed rationales. Designed for
graduate-level nursing students, the content spans the full spectrum of women's health, including reproductive
physiology, antenatal and postnatal care, gynecological pathologies, and advanced nursing management. Each
question is crafted to test clinical reasoning and application of evidence-based guidelines, with rationales that
explain correct and incorrect options. The document is updated to reflect the latest 2026/2027 academic standards,
incorporating recent research findings and professional recommendations. Emphasis is placed on high-stakes
topics such as high-risk pregnancies, oncological screening, and ethical decision-making. This resource serves as
a definitive study tool for achieving a graded A+ performance on the final exam.
Keywords:
Women's Health Nursing, Advanced Nursing, Final Exam Prep, 250 Questions, Rationales, 2026/2027, Graduate
Nursing, Clinical Reasoning
Answer Format:
Each question is followed by the correct answer and a comprehensive rationale explaining why the answer is
correct and why the other options are incorrect. Distractors are analyzed to highlight common misconceptions and
clinical pitfalls, reinforcing key concepts and promoting deep understanding.
Compliance Checklist:
Aligned with 2026-2027 curriculum standards for N582
Verified answers by subject matter experts
Page 1
, Rationales cite current evidence-based sources
Covers all major content domains as per course syllabus
Updated to include latest clinical guidelines and research
Suitable for self-assessment and exam simulation
Content Area Overview:
Content Area Questions Key Topics Weight
Reproductive Health and Family 1-50 Contraception, fertility, preconception 20%
Planning counseling, STI management, menstrual
disorders
Pregnancy and Prenatal Care 51-100 Antenatal assessment, gestational diabetes, 20%
preeclampsia, multiple gestation, prenatal
screening
Intrapartum and Postpartum Care 101-150 Labor management, postpartum hemorrhage, 20%
breastfeeding, postpartum depression,
neonatal transition
Gynecological Disorders and 151-200 Uterine fibroids, endometriosis, PCOS, 20%
Menopause menopause management, osteoporosis,
pelvic floor disorders
Advanced Nursing Interventions 201-250 Advanced assessment, pharmacotherapy, 20%
and Ethics surgical care, ethical dilemmas, legal issues,
patient education
Page 2
,Q1. A 32-year-old woman presents with pelvic pain and irregular bleeding. Transvaginal ultrasound reveals
a complex adnexal mass with solid components and papillary projections. CA-125 is elevated at 350 U/mL.
Which of the following is the most appropriate next step in management?
A. Repeat CA-125 in 3 months
B. Laparoscopic cystectomy with frozen section
C. CT scan of abdomen and pelvis
D. Start oral contraceptives
Correct Answer: C. CT scan of abdomen and pelvis
Rationale: Given the complex mass with solid components and elevated CA-125, there is high suspicion for ovarian
malignancy. A CT scan of abdomen and pelvis is essential for staging and to assess for metastatic disease before
surgical planning. Repeat CA-125 or oral contraceptives delay diagnosis. Laparoscopic cystectomy without prior
staging may be inadequate for cancer.
Why Wrong:
A - Repeat CA-125 delays definitive diagnosis; imaging is needed first.
B - Laparoscopic cystectomy without preoperative staging risks incomplete surgery if malignancy is
confirmed.
D - Oral contraceptives are not indicated for suspected malignancy.
Reference: National Comprehensive Cancer Network (NCCN) Guidelines: Ovarian Cancer, 2024.
Q2. A 28-year-old primigravida at 20 weeks gestation presents with a blood pressure of 155/100 mmHg and
2+ proteinuria on dipstick. She has no prior history of hypertension. Which of the following laboratory
findings is most consistent with preeclampsia with severe features?
A. Platelet count 150,000/L
B. Serum creatinine 1.2 mg/dL
C. AST 45 U/L
D. LDH 800 U/L
Correct Answer: D. LDH 800 U/L
Rationale: Preeclampsia with severe features is diagnosed with severe hypertension and evidence of end-organ
damage. LDH > 600 U/L indicates microangiopathic hemolysis, a feature of HELLP syndrome, which is a severe
variant. Platelet count < 100,000, creatinine > 1.1 mg/dL, and AST > 70 U/L are other criteria, but LDH elevation
is the most consistent with severe disease here.
Why Wrong:
A - Platelet count 150,000 is within normal range; severe preeclampsia requires < 100,000.
B - Creatinine 1.2 mg/dL is elevated slightly but not diagnostic alone; LDH is more specific for hemolysis.
C - AST 45 U/L is mildly elevated but not meeting severe criteria (>70).
Reference: ACOG Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia, 2020.
Page 3
, Q3. A 45-year-old woman with a history of stage I estrogen receptor-positive breast cancer treated with
tamoxifen presents with new-onset vaginal bleeding. Endometrial biopsy shows complex atypical hyperplasia.
Which of the following is the most likely cause?
A. Tamoxifen-induced endometrial proliferation
B. Recurrence of breast cancer
C. Endometrial polyp
D. Endometrial atrophy
Correct Answer: A. Tamoxifen-induced endometrial proliferation
Rationale: Tamoxifen, a selective estrogen receptor modulator, has partial estrogenic effects on the endometrium,
increasing the risk of endometrial hyperplasia and cancer. Complex atypical hyperplasia is a precursor to
endometrial cancer and is a known adverse effect of tamoxifen. Breast cancer recurrence in the endometrium is
rare. Polyps and atrophy are less likely given the histology.
Why Wrong:
B - Breast cancer metastasis to endometrium is uncommon and not typical with tamoxifen use.
C - Endometrial polyps are common but do not explain complex atypical hyperplasia.
D - Endometrial atrophy is associated with postmenopausal bleeding but not hyperplasia.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 53.
Q4. A 30-year-old woman with polycystic ovary syndrome (PCOS) is being evaluated for infertility. She has a
BMI of 32 kg/m² and oligomenorrhea. Her partner's semen analysis is normal. Which of the following is the
most appropriate first-line pharmacologic treatment for ovulation induction?
A. Clomiphene citrate
B. Metformin
C. Letrozole
D. Gonadotropins
Correct Answer: C. Letrozole
Rationale: Current guidelines recommend letrozole as first-line for ovulation induction in PCOS due to higher live
birth rates and lower multiple pregnancy rates compared to clomiphene. Clomiphene is second-line. Metformin is
used for metabolic issues but not primary ovulation induction. Gonadotropins are reserved for
clomiphene/letrozole failures due to cost and risk.
Why Wrong:
A - Clomiphene is less effective than letrozole in PCOS with higher multiple pregnancy risk.
B - Metformin improves ovulation rates but is not first-line for ovulation induction.
D - Gonadotropins are more expensive and carry higher risk of multiples; reserved after oral agents fail.
Reference: Practice Committee of the ASRM. (2023). Use of letrozole for ovulation induction. Fertil Steril.
Page 4
